$1.03
-0.02-1.9%
Ult. Agg.: Oct 29, 7:49 PM
XORTX Therapeutics (XRTX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | — | — | $-1.60 | $-1.60 |
| Actual | $-1.05 | $-0.58 | $-0.45 | $-0.65 |
| Surprise | — | — | +71.9% | +59.4% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | — | — |
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q4 | Feb 27, 2026 | $-0.45 | $-1.60 | 71.9 % |
| Q3 | Nov 17, 2025 | $-0.65 | $-1.60 | 59.4 % |
| Q4 | May 10, 2024 | $6.80 | $-2.20 | 409.1 % |
| Q3 | Nov 16, 2023 | $-3.35 | $-0.95 | -252.6 % |